Clinical Investigation of a Monofocal Toric Intra Ocular Lens (IOL) in Cataractous Eyes
PHY2107
Clinical Investigation of the Monofocal Toric IOL POD T 49P in Cataractous Eyes
1 other identifier
interventional
42
1 country
4
Brief Summary
This is a Multi-center, single-arm and non-masked study whereby patients undergoing routine cataract surgery be implanted with a hydrophobic acrylic monofocal toric intraocular lens PODEYE TORIC (model POD T 49P).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Dec 2021
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 26, 2021
CompletedStudy Start
First participant enrolled
December 24, 2021
CompletedFirst Posted
Study publicly available on registry
February 24, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2023
CompletedJuly 19, 2023
July 1, 2023
1.2 years
November 26, 2021
July 18, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Uncorrected visual acuity at Visit 4
Uncorrected visual acuity at 5 m will be measured. Convert decimal visual acuity to logMAR value using the following formula. logMAR value = log10 (1/decimal visual acuity)
Postoperative Day 120-180
Amount of astigmatism at Visit 4
Manifest cylindrical refraction for Best Collected Distance Visual Acuity will be measured at Visit 4.
Postoperative Day 120-180
Secondary Outcomes (3)
Best Corrected Distance Visual Acuity
Pre-Op, 1 week postoperative, 1 month postoperative, 6 months postoperative.
Manifest cylindrical refraction
Pre-Op, 1 month postoperative, 6 months postoperative
IOL rotation
Pre-Op, 1 month postoperative, 6 months postoperative
Other Outcomes (9)
Intraocular pressure (IOP) measurement
Pre-Op, 1 day postoperative, 1 week postoperative, 1 month postoperative, 6 months postoperative
Slitlamp examination - Corneal Status
Pre-Op, 1 day postoperative, 1 week postoperative, 1 month postoperative, 6 months postoperative
Fundus examination with dilated pupil
Pre-Op, 1 day postoperative, 1 week postoperative, 1 month postoperative, 6 months postoperative
- +6 more other outcomes
Study Arms (1)
PODEYE Toric Intra Ocular Lens Implantation experimental
EXPERIMENTALImplantation of PODEYE toric intraocular lenses.
Interventions
The investigational lens will be implanted within the capsular bag after removal of the natural crystalline lens following phacoemulsification and alignment the toric axis of investigational lens to the intend axis which was calculated by the Toric calculator software. When enroll the test lenses into both eyes, the lens is implanted first to the eye with more advanced cataract. If both eyes have a similar degree of cataract, perform the surgery first for the right eye. The timing of surgery the investigational lens into the fellow eye will be determined after the investigator and the investigator (hereinafter referred to as the investigator) have confirmed the safety of the previously operated eye.
Eligibility Criteria
You may qualify if:
- and 6: Cataract extraction is the indication of the clinical study. 2 and 3: One of GCP requirements 4 and 5: Essential condition for implant of the investigational lens. 7 and 8: Conditions to minimize the potential non-IOL factors which may affect the visual acuity data
You may not qualify if:
- Subjects with diseases that affect postoperative visual acuity in the cornea (keratitis, corneal degeneration, corneal dilatation, corneal edema);
- Previous corneal transplant;
- Previous refractive surgery;
- Irregular corneal aberration
- Subjects with diseases that affect postoperative visual acuity in the retina (retinal degeneration, diabetic retinopathy, retinal detachment);
- Poor mydriasis;
- Glaucoma or ocular hypertension;
- Optic nerve atrophy;
- Extremely shallow anterior chamber;
- Aniridia;
- Iris neovascularization;
- Microphthalmos;
- Amblyopia;
- Rubella, atopic or traumatic cataract;
- Recurrent severe anterior or posterior segment inflammation of unknown etiology;
- +15 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
Chukyo Eye Clinic
Nagoya, Aichi-ken, Japan
Roppongi Shiba Eye Clinic
Minato-Ku, Tokyo, Japan
Miyata Eye Hospital
Miyazaki, Japan
Fujita Eye Clinic
Tokushima, Japan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
MIYATA Kazunori, MD
Miyata Eye Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 26, 2021
First Posted
February 24, 2022
Study Start
December 24, 2021
Primary Completion
February 28, 2023
Study Completion
February 28, 2023
Last Updated
July 19, 2023
Record last verified: 2023-07
Data Sharing
- IPD Sharing
- Will not share